PMA supplement
P890066 S004: THERASONIC LITHOTRIPSY TREATMENT SYSTEM
FDA PMA supplement · Normal 180 Day Track · Focus Surgery, Inc.
Key facts
| Original PMA | P890066 |
|---|---|
| Supplement number | S004 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Other |
| Trade name | THERASONIC LITHOTRIPSY TREATMENT SYSTEM |
| Generic name | Lithotriptor, extracorporeal shock-wave, urological |
| Applicant | Focus Surgery, Inc. |
| Product code | LNS |
| Received date | Mar 10, 1992 |
| Decision date | Mar 26, 1992 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: